| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,298,000 | 10,994,000 | 9,198,000 | 10,943,000 | | Cost of Revenue | 10,955,000 | 10,582,000 | 9,063,000 | 10,434,000 | | | Gross Profit | 343,000 | 412,000 | 135,000 | 509,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 349,000 | 309,000 | 294,000 | 369,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (6,000) | 103,000 | (159,000) | 140,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 185,000 | 359,000 | 10,000 | (465,000) | | Earnings Before Interest And Taxes | 179,000 | 462,000 | (149,000) | (325,000) | | Interest Expense | 79,000 | 66,000 | 67,000 | 76,000 | | Income Before Tax | 100,000 | 396,000 | (216,000) | (401,000) | | Income Tax Expense | (97,000) | 79,000 | (34,000) | (214,000) | | Minority Interest | 35,000 | (28,000) |
-
| (30,000) | | | | Net Income From Continuing Ops | 232,000 | 294,000 | (176,000) | (210,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 232,000 | 294,000 | (176,000) | (210,000) | | Preferred Stock And Other Adjustments |
-
| (1,000) | (38,000) | (20,000) | | | Net Income Applicable To Common Shares | $232,000 | $293,000 | ($214,000) | ($230,000) |
|
0.51% Nasdaq 
Income Statement
